Understanding and managing symptom effects of cerebral oedema in high-grade glioma patients: a review of the literature

High-grade glioma (HGG) is a primary brain tumour which is associated with a high mortality rate. An HGG diagnosis is an overwhelming experience for patients and their families, with patients suffering from a range of symptoms associated with disease progression and treatment resulting in poor outcomes and quality of life. For the neuro-oncology nurse, it is difficult to deliver comprehensive health care to this patient group. A search of the literature was conducted for the years 2004 through September 2015. Based on predefined criteria, 16 records were retrieved for review with a major focus on symptoms and treatment of cerebral oedema. The findings were grouped based on emerging categories relating to treatment and management of cerebral oedema, quality of life, functionality and psychological health and nursing assessment and interventions. This article aims to provide health care professionals with a better understanding of the symptom management and effects of cerebral oedema in HGG patients.